The chipmaker's shares hit new records on lots of good news, and there's plenty to be excited about for the future. The post ...
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback